Seeking Alpha

Dominic Rodrigues'  Instablog

Dominic Rodrigues
Send Message
Pursuing entrepreneurship through corporate development and investment management, by raising, investing, developing and managing money across a range of activities that include board and advisory roles, portfolio management, private equity, trading, senior and start-up company management, and... More
My blog:
Connecting the dots...Provectus Biopharmaceuticals
  • A Fool's Game, A Grand Quest, And Part I Of An Epic Outcome 0 comments
    Mar 31, 2013 12:33 AM | about stocks: PVCT

    Taken From Connecting The Dots...Provectus Pharmaceuticals (March 21, 2013).

    It is without a doubt a fool's game to predict the regulatory path to approval of a drug. True to form, and in no small part because of a need to be right (a trait that drives my passion for investment management), I tried many times to do so. If I had a much deeper background in life sciences investing, perhaps I could have spared myself and the readers of this blog errors and inefficiency in thinking and analysis.

    Then again, while more informed, shrewd and knowledgeable money in this space - classic examples of conventional-thinking money - very often are on the cutting edge of being in the right place at the right time, I do not think they understand paradigm shifts any more than other like-minded, industry-oriented money.

    A blog reader asked me to describe how I arrived at my stock position in Provectus. Greatly simplifying the answer, I reply by saying I made a two-bet parlay. First, I bet that management could demonstrate the tremendous, multi-indication efficacy of an incredibly safe drug compound. Second, I bet that management could and would protect Rose Bengal's economics in a size and scope commensurate with the depth and breadth of their innovation.

    The risk-reward of my investment in the company eventually matched the clinical and commercial risk-reward of the drug.

    PV-10 (as well as PH-10 and the family of halogenated xanthenes) is the culmination of Craig's scientific career, a quest of three principals that (as far as I know) began at Oak Ridge National Labs, was and continues to be facilitated by No. 4, and includes numerous professional, personal, emotional and financial ups and downs.

    This company and this situation also represent a quest for me: the eventual realization of a seminal investment in my career to date; the never-ending hunger to be right; the tangible and intangible satisfaction, results and provision of future professional and personal means that only a financial moonshot yield; and, a unique opportunity to continue to successfully build my investment management career as, how and when I see fit if ultimately right.

    In further answering the reader's inquiry, there reached a point in my due diligence, analyses and conclusions when and where I found that, over time by periodic buying of shares, I had pushed every discretionary dollar I (we) owned into a capital pool with the express purpose and intent of owning as many shares as I (we) possibly could.

    I never imagined the first bet of my parlay would turn out to be epic in nature. On April 8th, Moffitt raises the curtain on PV-10.

    Management's next task is to optimize ROI, an effort that is no small feat. And while thus far they have protected the economics of the opportunity, which could be enormous, a great outcome is not yet assured.

    I await the outcome of the second bet of my parlay after AACR, because in Vegas you can't cash in your ticket at the window until the results of all bets are tallied.

    Disclosure: I am long OTC:PVCT.

    Additional disclosure: I am a large shareholder of Provectus Pharmaceuticals, have not sold any shares as of this Instablog submission, and also author the blog "Connecting the dots...Provectus Pharmaceuticals."

    Themes: Biotechnology Stocks: PVCT
Back To Dominic Rodrigues' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

Latest Comments

Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.